Consequences and progress of Takeda-Shire Buyout
Takeda announced in April it would buy Shire in the largest-ever overseas acquisition by a Japanese company. Although Shire is based in... Read More
Big Pharma Acquisition: Takeda to acquire Shire for $62 billion
Takeda Pharmaceutical Co. of Japan has finalized an agreement to buy Shire PLC, the second-biggest biotech employer in Massachusetts, for $62 billion... Read More
Case Analysis: US FDA approval of Shire’s Mydayis
Shire has announced that the US Food and Drug Administration (FDA) has approved Mydayis (mixed salts of a single-entity amphetamine product), a... Read More
USFDA approved Xiidra (lifitegrast ophthalmic solution) for dry eye disease
Brand Name: Xiidra Molecule: lifitegrast ophthalmic solution Drug Class: Lymphocyte function-associated antigen 1 (LFA-1) antagonist Approved for: Dry Eyes Manufactured By: Shire... Read More
Highlights of Shire – Baxalta Deal
Posted on18 Jan 2016
Comments0
Shire acquires drug maker Baxalta on recently announced deal valued at about $32 billion. The combination would create a giant in the treatment... Read More
Shire is to acquire Meritage Pharma
Posted on25 Feb 2015
Comments0
Acquiring Company: Shire plc Company to acquire: Meritage Pharma Why is Shire acquiring Meritage Pharma? Shire is to acquire San Diego-based Meritage Pharma... Read More